UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of the Estrogen Pathway in the Tumor Microenvironment

International journal of molecular sciences, 2018-02, Vol.19 (2), p.611

2018

Volltextzugriff (PDF)

Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications

Frontiers in oncology, 2020-02, Vol.10, p.137-137

2020

Volltextzugriff (PDF)

Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective study

Scientific reports, 2023-10, Vol.13 (1), p.17047-17047, Article 17047

2023

Volltextzugriff (PDF)

Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer

Nature communications, 2018-11, Vol.9 (1), p.4589-11, Article 4589

2018

Volltextzugriff (PDF)

Targeting the ERβ/HER Oncogenic Network in KRAS Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy

International journal of molecular sciences, 2021-12, Vol.23 (1), p.81

2021

Volltextzugriff (PDF)

Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence

The Journal of biological chemistry, 2018-02, Vol.293 (5), p.1794-1809

2018

Volltextzugriff (PDF)

Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration

Cancer research (Chicago, Ill.), 2019-06, Vol.79 (11), p.2962-2977

2019

Volltextzugriff (PDF)

Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

Clinical cancer research, 2011-07, Vol.17 (13), p.4425-4438

2011

Volltextzugriff (PDF)

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

Clinical cancer research, 2013-01, Vol.19 (2), p.380-392

2013

Volltextzugriff (PDF)

HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer

Clinical cancer research, 2009-06, Vol.15 (11), p.3740-3750

2009

Volltextzugriff (PDF)

MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance

Molecular oncology, 2017-06, Vol.11 (6), p.628-639

2017

Volltextzugriff (PDF)

CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma

Cell & bioscience, 2024-10, Vol.14 (1), p.127-14, Article 127

2024

Volltextzugriff (PDF)

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (4), p.1459-1470

2005

Volltextzugriff (PDF)

Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome

Neoplasia (New York, N.Y.), 2015-11, Vol.17 (11), p.817-825

2015

Volltextzugriff (PDF)

Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells

The Journal of steroid biochemistry and molecular biology, 2009-08, Vol.116 (1), p.102-109

2009

Volltextzugriff (PDF)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer

Cancers, 2020-06, Vol.12 (6), p.1537

2020

Volltextzugriff (PDF)

Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2009-11, Vol.15 (21), p.6529-6540

2009

Volltextzugriff (PDF)

Estrongenic Steroid Hormones in Lung Cancer

Seminars in oncology, 2014-02, Vol.41 (1), p.5-16

2014

Volltextzugriff (PDF)

Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden

JCI insight, 2021-02, Vol.6 (3)

2021

Volltextzugriff (PDF)

Estrogen Receptor ß in Cancer: To ß(e) or not to ß(e)?

Endocrinology (Philadelphia), 2021-11, Vol.162 (11)

2021

Volltextzugriff (PDF)

The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases

Clinical lung cancer, 2024-09, Vol.25 (6), p.483-501

2024

Volltextzugriff (PDF)

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment

Cancers, 2017-04, Vol.9 (4), p.39

2017

Volltextzugriff (PDF)

Targeting the estrogen pathway for the treatment and prevention of lung cancer

Lung cancer management, 2014-02, Vol.3 (1), p.43-52

2014

Volltextzugriff (PDF)

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases

The oncologist (Dayton, Ohio), 2022-10, Vol.27 (10), p.839-848

2022

Volltextzugriff (PDF)

Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone

Methods in molecular biology (Clifton, N.J.), 2020, Vol.2102, p.149

2020

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(116)
Buchkapitel
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(63)
Humans
(49)
Oncology
(43)
Animals
(31)
Lung Cancer
(30)
Female
(28)
Mice
(27)
Lung Neoplasms - Pathology
(25)
Male
(21)
Lung Neoplasms - Metabolism
(17)
Cell Line, Tumor
(16)
Lung Neoplasms - Genetics
(16)
Tumors
(16)
Mutation
(14)
Biochemistry & Molecular Biology
(12)
Biological And Medical Sciences
(12)
Respiratory System
(12)
Carcinoma, Non-Small-Cell Lung - Metabolism
(11)
Carcinoma, Non-Small-Cell Lung - Pathology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Role of the Estrogen Pathway in the Tumor Microenvironment

Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications

Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective study

Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer

Targeting the ERβ/HER Oncogenic Network in KRAS Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy

Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence

Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration

Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer

MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance

CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects

Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome

Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer

Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma

Estrongenic Steroid Hormones in Lung Cancer

Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden

Estrogen Receptor ß in Cancer: To ß(e) or not to ß(e)?

The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment

Targeting the estrogen pathway for the treatment and prevention of lung cancer

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases

Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone

Suchergebnisse filtern